Free Trial

iRadimed (IRMD) Competitors

iRadimed logo
$77.58 +2.09 (+2.77%)
Closing price 04:00 PM Eastern
Extended Trading
$77.58 0.00 (0.00%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IRMD vs. SLNO, NVST, LIVN, WRBY, INSP, EYE, LQDA, LMAT, AORT, and PRCT

Should you be buying iRadimed stock or one of its competitors? The main competitors of iRadimed include Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Warby Parker (WRBY), Inspire Medical Systems (INSP), National Vision (EYE), Liquidia Technologies (LQDA), LeMaitre Vascular (LMAT), Artivion (AORT), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical equipment" industry.

iRadimed vs. Its Competitors

Soleno Therapeutics (NASDAQ:SLNO) and iRadimed (NASDAQ:IRMD) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, dividends, profitability, analyst recommendations, institutional ownership, media sentiment, risk and valuation.

iRadimed has a net margin of 26.61% compared to Soleno Therapeutics' net margin of 0.00%. iRadimed's return on equity of 23.30% beat Soleno Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Soleno TherapeuticsN/A -73.74% -56.67%
iRadimed 26.61%23.30%20.62%

Soleno Therapeutics presently has a consensus target price of $115.92, indicating a potential upside of 73.27%. iRadimed has a consensus target price of $72.00, indicating a potential downside of 7.19%. Given Soleno Therapeutics' higher probable upside, research analysts plainly believe Soleno Therapeutics is more favorable than iRadimed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Soleno Therapeutics
1 Sell rating(s)
0 Hold rating(s)
12 Buy rating(s)
1 Strong Buy rating(s)
2.93
iRadimed
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Soleno Therapeutics had 10 more articles in the media than iRadimed. MarketBeat recorded 13 mentions for Soleno Therapeutics and 3 mentions for iRadimed. iRadimed's average media sentiment score of 0.95 beat Soleno Therapeutics' score of 0.68 indicating that iRadimed is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Soleno Therapeutics
5 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
iRadimed
1 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

97.4% of Soleno Therapeutics shares are held by institutional investors. Comparatively, 92.3% of iRadimed shares are held by institutional investors. 6.4% of Soleno Therapeutics shares are held by company insiders. Comparatively, 36.8% of iRadimed shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

iRadimed has higher revenue and earnings than Soleno Therapeutics. Soleno Therapeutics is trading at a lower price-to-earnings ratio than iRadimed, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Soleno TherapeuticsN/AN/A-$175.85M-$4.14-16.16
iRadimed$73.24M13.47$19.23M$1.6247.89

Soleno Therapeutics has a beta of -2.75, indicating that its stock price is 375% less volatile than the S&P 500. Comparatively, iRadimed has a beta of 1.02, indicating that its stock price is 2% more volatile than the S&P 500.

Summary

iRadimed beats Soleno Therapeutics on 11 of the 16 factors compared between the two stocks.

Get iRadimed News Delivered to You Automatically

Sign up to receive the latest news and ratings for IRMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

IRMD vs. The Competition

MetriciRadimedMED INSTRUMENTS IndustryMedical SectorNASDAQ Exchange
Market Cap$959.86M$7.31B$6.18B$10.67B
Dividend Yield0.90%1.14%5.72%4.86%
P/E Ratio47.8927.2629.0927.12
Price / Sales13.4727.68584.14126.40
Price / Cash47.7122.2737.1261.42
Price / Book11.335.2312.246.43
Net Income$19.23M$178.09M$3.33B$276.63M
7 Day Performance6.06%-1.70%-1.46%-2.60%
1 Month Performance9.72%1.07%5.03%0.31%
1 Year Performance52.27%0.77%61.45%30.63%

iRadimed Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
IRMD
iRadimed
4.6922 of 5 stars
$77.58
+2.8%
$72.00
-7.2%
+47.4%$959.86M$73.24M47.89110Insider Trade
SLNO
Soleno Therapeutics
4.2854 of 5 stars
$64.27
+0.8%
$115.92
+80.4%
+24.9%$3.39BN/A-15.5230
NVST
Envista
3.8568 of 5 stars
$19.23
+0.9%
$21.08
+9.6%
+8.1%$3.17B$2.51B60.1012,300
LIVN
LivaNova
2.8187 of 5 stars
$51.78
+2.2%
$59.71
+15.3%
+3.7%$2.77B$1.25B-13.312,900
WRBY
Warby Parker
2.2902 of 5 stars
$22.17
-0.4%
$24.75
+11.7%
+19.4%$2.34B$821.35M-316.613,780Positive News
Gap Up
INSP
Inspire Medical Systems
4.8394 of 5 stars
$77.57
+3.2%
$150.50
+94.0%
-59.2%$2.22B$802.80M44.841,246
EYE
National Vision
2.6642 of 5 stars
$26.37
+3.2%
$24.73
-6.2%
+156.8%$2.02B$1.82B-146.5013,411News Coverage
Positive News
LQDA
Liquidia Technologies
3.5949 of 5 stars
$23.77
+2.5%
$32.38
+36.2%
+112.7%$2.00B$14M-13.9850Analyst Forecast
LMAT
LeMaitre Vascular
3.372 of 5 stars
$85.31
-0.9%
$97.60
+14.4%
+1.3%$1.95B$219.86M41.41490
AORT
Artivion
2.6218 of 5 stars
$40.63
+1.1%
$43.97
+8.2%
+59.0%$1.90B$405.04M-96.741,600
PRCT
PROCEPT BioRobotics
3.0253 of 5 stars
$33.00
+0.2%
$70.00
+112.1%
-49.3%$1.83B$224.50M-21.29430Upcoming Earnings

Related Companies and Tools


This page (NASDAQ:IRMD) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners